Platelet-to-lymphocyte ratio is not a predictor of clinically significant prostate cancer at the prostate biopsy: A large cohort study
Abstract Previous studies have reported conflicting results on the predictive role of the platelet-to-lymphocyte ratio (PLR) in detecting clinically significant prostate cancer (CSPCa) at the time of prostate biopsies. We explored the predictive value of pre-biopsy PLRs for CSPCa using our large-coh...
Guardado en:
Autores principales: | Jeong Woo Lee, Hyeon Jeong, Hwancheol Son, Min Chul Cho |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dab04702858249509bfddb86aba5c1b2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels
por: Seokhwan Bang, et al.
Publicado: (2021) -
Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer
por: Samuel Carbunaru, et al.
Publicado: (2021) -
The effect and correlation of smoking with platelet indices, neutrophil lymphocyte ratio and platelet lymphocyte ratio
por: Mukta Pujani, et al.
Publicado: (2021) -
Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer
por: Corrado Pedrazzani, et al.
Publicado: (2017) -
The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy
por: Chung Un Lee, et al.
Publicado: (2021)